Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Seed
Series B
Focus Areas
BioTech
Pharmaceuticals
About Investor
Ash Khanna is a Partner at Pivotal bioVenture Partners, based in the San Francisco Bay Area. He focuses on biotech, pharmaceuticals, and diagnostics, from seed through Series B. His typical check sizes range from $100K – $5M. Ash brings deep domain expertise in life sciences, backing companies advancing novel therapeutics and healthcare innovations.
Previous investments
Evommune
50M |2023
83M |2021
13M |2020
HotSpot Therapeutics
100M |2021
Bolt Biotherapeutics
94M |2020
54M |2019
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free